Literature DB >> 22285784

Cargo distributions differentiate pathological axonal transport impairments.

Cassie S Mitchell1, Robert H Lee.   

Abstract

Axonal transport is an essential process in neurons, analogous to shipping goods, by which energetic and cellular building supplies are carried downstream (anterogradely) and wastes are carried upstream (retrogradely) by molecular motors, which act as cargo porters. Impairments in axonal transport have been linked to devastating and often lethal neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis, Huntington's, and Alzheimer's. Axonal transport impairment types include a decrease in available motors for cargo transport (motor depletion), the presence of defective or non-functional motors (motor dilution), and the presence of increased or larger cargos (protein aggregation). An impediment to potential treatment identification has been the inability to determine what type(s) of axonal transport impairment candidates that could be present in a given disease. In this study, we utilize a computational model and common axonal transport experimental metrics to reveal the axonal transport impairment general characteristics or "signatures" that result from three general defect types of motor depletion, motor dilution, and protein aggregation. Our results not only provide a means to discern these general impairments types, they also reveal key dynamic and emergent features of axonal transport, which potentially underlie multiple impairment types. The identified characteristics, as well as the analytical method, can be used to help elucidate the axonal transport impairments observed in experimental and clinical data. For example, using the model-predicted defect signatures, we identify the defect candidates, which are most likely to be responsible for the axonal transport impairments in the G93A SOD1 mouse model of ALS. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285784      PMCID: PMC3500886          DOI: 10.1016/j.jtbi.2012.01.019

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  64 in total

1.  Rapid intermittent movement of axonal neurofilaments observed by fluorescence photobleaching.

Authors:  L Wang; A Brown
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

2.  Effect of vesicle traps on traffic jam formation in fast axonal transport.

Authors:  A V Kuznetsov
Journal:  Math Biosci       Date:  2010-05-24       Impact factor: 2.144

3.  Stochastic simulation of neurofilament transport in axons: the "stop-and-go" hypothesis.

Authors:  Anthony Brown; Lei Wang; Peter Jung
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

Review 4.  Pathogenic superoxide dismutase structure, folding, aggregation and turnover.

Authors:  P John Hart
Journal:  Curr Opin Chem Biol       Date:  2006-03-03       Impact factor: 8.822

5.  The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

Authors:  Nichole E LaPointe; Gerardo Morfini; Gustavo Pigino; Irina N Gaisina; Alan P Kozikowski; Lester I Binder; Scott T Brady
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

6.  Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.

Authors:  Robert H Baloh; Robert E Schmidt; Alan Pestronk; Jeffrey Milbrandt
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

7.  Cytoplasmic dynein, the dynactin complex, and kinesin are interdependent and essential for fast axonal transport.

Authors:  M Martin; S J Iyadurai; A Gassman; J G Gindhart; T S Hays; W M Saxton
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

Review 8.  Dysregulation of axonal transport and motorneuron diseases.

Authors:  Daniela Sau; Paola Rusmini; Valeria Crippa; Elisa Onesto; Elena Bolzoni; Antonia Ratti; Angelo Poletti
Journal:  Biol Cell       Date:  2011-02       Impact factor: 4.458

9.  Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation.

Authors:  B Zhang; P Tu; F Abtahian; J Q Trojanowski; V M Lee
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

10.  A stochastic model for microtubule motors describes the in vivo cytoplasmic transport of human adenovirus.

Authors:  Mattia Gazzola; Christoph J Burckhardt; Basil Bayati; Martin Engelke; Urs F Greber; Petros Koumoutsakos
Journal:  PLoS Comput Biol       Date:  2009-12-24       Impact factor: 4.475

View more
  7 in total

1.  Axonal transport cargo motor count versus average transport velocity: is fast versus slow transport really single versus multiple motor transport?

Authors:  Robert H Lee; Cassie S Mitchell
Journal:  J Theor Biol       Date:  2015-01-20       Impact factor: 2.691

2.  Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Authors:  Cameron W Irvin; Renaid B Kim; Cassie S Mitchell
Journal:  Front Cell Neurosci       Date:  2015-07-01       Impact factor: 5.505

Review 3.  State of the field: An informatics-based systematic review of the SOD1-G93A amyotrophic lateral sclerosis transgenic mouse model.

Authors:  Renaid B Kim; Cameron W Irvin; Keval R Tilva; Cassie S Mitchell
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-05-22       Impact factor: 4.092

4.  A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy.

Authors:  Leila Bond; Kamren Bernhardt; Priyank Madria; Katherine Sorrentino; Hailee Scelsi; Cassie S Mitchell
Journal:  Front Neurosci       Date:  2018-01-24       Impact factor: 4.677

5.  Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling.

Authors:  Jillian L Shaw; Karen T Chang
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

6.  Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?

Authors:  Sabrina K Hollinger; Ike S Okosun; Cassie S Mitchell
Journal:  Front Neurol       Date:  2016-03-29       Impact factor: 4.003

7.  Characterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.

Authors:  Stephen R Pfohl; Martin T Halicek; Cassie S Mitchell
Journal:  J Neuromuscul Dis       Date:  2015-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.